BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Yang Y, Luo Y, Wang J, Lu X, Yang Z, Yang J. Prognostic potential of PRPF3 in hepatocellular carcinoma. Aging (Albany NY) 2020;12:912-30. [PMID: 31926109 DOI: 10.18632/aging.102665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Peng Q, Huang H, Zhu C, Hou Q, Wei S, Xiao Y, Zhang Z, Sun X, Ali Sheikh MS. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/8421813] [Reference Citation Analysis]
2 Hu X, Zhou J, Zhang Y, Zeng Y, Jie G, Wang S, Yang A, Zhang M. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. Front Genet 2022;13:942454. [DOI: 10.3389/fgene.2022.942454] [Reference Citation Analysis]
3 Huang D, Zhang H, Li L, Ge W, Liu W, Dong Z, Gao J, Yao N, Fu W, Huang L, Guo T, Sun Y, Teng X. Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms. Front Endocrinol 2022;13:854611. [DOI: 10.3389/fendo.2022.854611] [Reference Citation Analysis]
4 Wei L, Zou C, Chen L, Lin Y, Liang L, Hu B, Mao Y, Zou D. Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma. Front Mol Biosci 2022;9:876603. [DOI: 10.3389/fmolb.2022.876603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li Z, Wang R, Qiu C, Cao C, Zhang J, Ge J, Shi Y. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment. Front Immunol 2022;13:834606. [PMID: 35392073 DOI: 10.3389/fimmu.2022.834606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2022;19:257-73. [PMID: 35022608 DOI: 10.1038/s41575-021-00568-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
7 Li J, Song Y, Zhang C, Wang R, Hua L, Guo Y, Gan D, Zhu L, Li S, Ma P, Yang C, Li H, Yang J, Shi J, Liu X, Su H. TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Cell Mol Biol Lett 2022;27:24. [PMID: 35260078 DOI: 10.1186/s11658-022-00321-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu J, Gu L, Zhang D, Li W. Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients. Front Mol Biosci 2022;9:759792. [DOI: 10.3389/fmolb.2022.759792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang W, Liu Z, Xia S, Yao L, Li L, Gan Z, Tang H, Guo Q, Yan X, Sun Z. GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma. Aging (Albany NY) 2021;13:25304-24. [PMID: 34894398 DOI: 10.18632/aging.203748] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang C, Liu J, Guo H, Hong D, Ji J, Zhang Q, Guan Q, Ren Q. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered 2021;12:3159-76. [PMID: 34187307 DOI: 10.1080/21655979.2021.1946305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wu B, Tang X, Ke H, Zhou Q, Zhou Z, Tang S, Ke R. Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study. Pathol Oncol Res 2021;27:1609768. [PMID: 34257617 DOI: 10.3389/pore.2021.1609768] [Reference Citation Analysis]
12 Lin YR, Yang WJ, Yang GW. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma. Aging (Albany NY) 2021;13:12929-54. [PMID: 33952716 DOI: 10.18632/aging.202964] [Reference Citation Analysis]
13 Lu S, Cai S, Peng X, Cheng R, Zhang Y. Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma. Front Immunol 2021;12:636614. [PMID: 33868261 DOI: 10.3389/fimmu.2021.636614] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Chu Y, Yuan Z, He X, Dong Z, Páscoa JC. Model Construction and Performance Degradation Characteristics of a Deflector Jet Pressure Servo Valve under the Condition of Oil Contamination. International Journal of Aerospace Engineering 2021;2021:1-17. [DOI: 10.1155/2021/8840084] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Luo G, Xu J, Xia Z, Liu S, Liu H, He K, Xiang G. SSRP1 Is a Prognostic Biomarker Correlated with CD8+ T Cell Infiltration in Hepatocellular Carcinoma (HCC). Biomed Res Int 2021;2021:9409836. [PMID: 33688504 DOI: 10.1155/2021/9409836] [Reference Citation Analysis]
16 Lu S, Dai M, Hu X, Yi H, Zhang Y. A new survival model based on ion channel genes for prognostic prediction in hepatocellular carcinoma. Genomics 2021;113:171-82. [PMID: 33340691 DOI: 10.1016/j.ygeno.2020.12.028] [Reference Citation Analysis]
17 Zhou L, Ding L, Gong Y, Zhao J, Xin G, Zhou R, Zhang W. Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses. PeerJ 2020;8:e10269. [PMID: 33240622 DOI: 10.7717/peerj.10269] [Reference Citation Analysis]
18 Mo Z, Zhang S, Zhang S. A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma. J Oncol 2020;2020:8291036. [PMID: 33014055 DOI: 10.1155/2020/8291036] [Reference Citation Analysis]